Sanofi defends Garijo appointment, says it is 'fully committed' to immunology

April 23, 2026 05:00 AM EDTUpdated 11:03 AM R&DPharma Up­dat­ed: Sanofi de­fends Gar­i­jo ap­point­ment, says it is 'ful­ly com­mit­ted' to im­munol­o­gy Ayisha Sharma News Reporter Sanofi’s first-quar­ter earn­ings call with the me­dia on Thurs­day was an ex­er­cise in redi­rect­ing the nar­ra­tive be­fore its new CEO steps in next week. CFO … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER